$NGTF New Survey Reveals 79% of Americans Experience

New Post Public Reply Private Reply Replies (0) Message Board
jmtimz
178
$NGTF New Survey Reveals 79% of Americans Experience Increased Nighttime Cravings With the End of Daylight Saving Time
When Daylight Saving Time Ends, 'Daylight Cravings Time' begins. Shorter daylight hours increase out-of-control nighttime eating for the majority of Americans.

TARRYTOWN, N.Y., Nov. 1, 2021 /PRNewswire/ -- Nightfood Holdings, Inc. (OTCQB: NGTF) : As Americans are once again approaching the end of Daylight Saving Time (DST) on Sunday, November 7, a new national survey reveals widespread anxieties about the impact of fewer daylight hours on our diets and well-being.

A whopping 83% of Americans say that they sometimes or always feel out of control about their nighttime snacking. What's more, 79% of people report that their nighttime cravings for snacks increase when it gets dark earlier in the evening.

The survey, conducted on behalf of sleep-friendly ice cream Nightfood, adds to a growing list of evidence that the end of Daylight Saving Time has profound implications for our eating habits.

Additional key findings of the survey include:

91% of Americans snack between dinner and bedtime.

The most-craved nighttime snacks for Americans are:

67% of people say that they consider sleep quality when selecting a nighttime snack.

Of the 83% of Americans who say they feel out of control about their nighttime snacking, 45% say they sometimes feel this way, while 38% say they ALWAYS feel out of control about snacking at night

"Being aware that these cravings occur below the conscious level can help consumers better manage their impact," said Sean Folkson, Nightfood CEO and Founder. "We've long known that less sunlight exposure leads to a drop in serotonin levels and can negatively impact mood and sleep. It's not surprising that fewer daylight hours could wreak havoc on people's snacking behavior before bed."

https://finance.yahoo.com/news/survey-reveals...00612.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading